BEONE MEDICINES (BEIGF) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 2 6 sessions, November 6, 2025 to June 9, 2026
- Largest daily move
- -6.1% close of March 2, 2026
Company Description
BEONE MEDICINES (OTC: BEIGF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $32.3B.
BEIGF has declined 2.5% over the past month. The last closing price was $21.95.
For FY2025, BEONE MEDICINES reported revenue of $5.3B with net income of $286.9M and diluted earnings per share of $0.19. The company operates at a net profit margin of 5.4%.
This page collects what Stock Titan holds for BEIGF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BEONE MEDICINES (BEIGF) closed at $21.95 on June 9, 2026. Over the past month, the price has lost 2.5%.
BEIGF Metrics & Rankings
Price returns through June 9, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
BEONE MEDICINES has filed 5 recent SEC filings, including 3 Form 4, 2 Form 144. The most recent filing was submitted on September 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BEIGF SEC filings →
Financial Highlights
BEONE MEDICINES generated $5.3B in revenue in FY2025, retaining a 87.5% gross margin, operating income reached $447.1M (8.4% operating margin), and net income was $286.9M, reflecting a 5.4% net profit margin. Diluted earnings per share stood at $0.19. The company generated $1.1B in operating cash flow. With a current ratio of 3.41, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in BEONE MEDICINES (BEIGF) currently stands at 112.9 thousand shares, down 29.6% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has decreased by 71.2%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BEONE MEDICINES (BEIGF) currently stands at 1.6 days, down 87.8% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.8% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BEIGF Company Profile & Sector Positioning
BEONE MEDICINES (BEIGF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.